Literature DB >> 16452987

Stimulation of adenosine receptors selectively activates gene expression in striatal enkephalinergic neurons.

Marzena Karcz-Kubicha1, Sergi Ferré, Oscar Díaz-Ruiz, César Quiroz-Molina, Steven R Goldberg, Bruce T Hope, Marisela Morales.   

Abstract

In the striatum, adenosine A2A and dopamine D2 receptors exert reciprocal antagonistic interactions that modulate the function of GABAergic enkephalinergic neurons. We have previously shown that stimulation of adenosine A1 receptors allows the stimulation of A2A receptors to overcome a tonic inhibitory effect of D2 receptors and induce striatal expression of c-fos. In the present work, by studying co-localization of c-Fos immunoreactivity and preproenkephalin and preprodynorphin transcripts, we show that co-administration of the A1 receptor agonist CPA and the A2A receptor agonist CGS 21680 increases the striatal expression of c-fos in GABAergic enkephalinergic but not in GABAergic dynorphinergic neurons. Co-administration of CPA and CGS 21680 also induced a significant increase in the striatal expression of preproenkephalin. The results underscore the role of adenosine in the activation of gene expression in the GABAergic enkephalinergic neuron.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452987     DOI: 10.1038/sj.npp.1301035

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  10 in total

1.  Adenosine A2A receptors in the nucleus accumbens bi-directionally alter cocaine seeking in rats.

Authors:  Casey E O'Neill; McKenzie L LeTendre; Ryan K Bachtell
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

2.  Indirect basal ganglia pathway mediation of repetitive behavior: attenuation by adenosine receptor agonists.

Authors:  Yoko Tanimura; Sasha Vaziri; Mark H Lewis
Journal:  Behav Brain Res       Date:  2010-02-21       Impact factor: 3.332

Review 3.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

4.  Stimulation of adenosine receptors in the nucleus accumbens reverses the expression of cocaine sensitization and cross-sensitization to dopamine D2 receptors in rats.

Authors:  Benjamin D Hobson; Kathryn E Merritt; Ryan K Bachtell
Journal:  Neuropharmacology       Date:  2012-06-28       Impact factor: 5.250

5.  The adenosine A2A receptor agonist, CGS-21680, blocks excessive rearing, acquisition of wheel running, and increases nucleus accumbens CREB phosphorylation in chronically food-restricted rats.

Authors:  Soledad Cabeza de Vaca; Pavitra Kannan; Yan Pan; Nancy Jiang; Yanjie Sun; Kenneth D Carr
Journal:  Brain Res       Date:  2007-01-17       Impact factor: 3.252

6.  Differential effects of the adenosine A₂A agonist CGS-21680 and haloperidol on food-reinforced fixed ratio responding in the rat.

Authors:  Chris Jones-Cage; Thomas R Stratford; David Wirtshafter
Journal:  Psychopharmacology (Berl)       Date:  2011-09-07       Impact factor: 4.530

7.  Reduction of repetitive behavior by co-administration of adenosine receptor agonists in C58 mice.

Authors:  Mark H Lewis; Hemangi Rajpal; Amber M Muehlmann
Journal:  Pharmacol Biochem Behav       Date:  2019-05-02       Impact factor: 3.533

8.  Effects of adenosine A2A receptor stimulation on cocaine-seeking behavior in rats.

Authors:  Ryan K Bachtell; David W Self
Journal:  Psychopharmacology (Berl)       Date:  2009-07-30       Impact factor: 4.530

9.  Repetitive Behavior in Neurodevelopmental Disorders: Clinical and Translational Findings.

Authors:  Cristina M Whitehouse; Mark H Lewis
Journal:  Behav Anal       Date:  2015-06-20

10.  Pivotal Role of Adenosine Neurotransmission in Restless Legs Syndrome.

Authors:  Sergi Ferré; César Quiroz; Xavier Guitart; William Rea; Arta Seyedian; Estefanía Moreno; Verònica Casadó-Anguera; Manuel Díaz-Ríos; Vicent Casadó; Stefan Clemens; Richard P Allen; Christopher J Earley; Diego García-Borreguero
Journal:  Front Neurosci       Date:  2018-01-08       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.